The Sage Commons is a novel information platform being built by an international partnership of researchers and stakeholders to define the molecular basis of disease and guide the development of effective human therapeutics and diagnostics.
The Sage Commons will be used to integrate diverse molecular mega-data sets, to build predictive bionetworks and to offer advanced tools proven to provide unique new insights into human disease biology. Users will also be contributors that advance the knowledge base and tools through their cumulative participation.
The public access mission of the Sage Commons requires the development of a new strategic and legal framework to protect the rights of contributors while providing widespread access to integrative genomics resources.
Andrew Kasarskis, PhD is Head of Strategic Initiatives at Sage BioNetworks.
Mr. Kupershmidt leads NextBio's product, scientific computing and content groups. His team includes PhDs and MDs from leading academic institutions with extensive experience in genomics, computational biology and clinical research. Mr. Kupershmidt has a decade of experience in the design and implementation of genomic solutions for organizations involved in basic and translational research, as well as drug discovery.
Prior to NextBio, Mr. Kupershmidt was the Director of Professional Services at Silicon Genetics. There he helped develop and customize software solutions for the analysis and management of high throughput data generated by genomic and proteomic technologies. Mr. Kupershmidt joined Silicon Genetics as an early stage startup and successfully worked with hundreds of academic institutions and commercial enterprises.
Previously, Mr. Kupershmidt carried out research as a geneticist at the UCSD Howard Hughes Medical Institute where he studied transcriptional mechanisms of gene expression regulation during pituitary development. Mr. Kupershmidt is currently a PhD candidate at the SciLifeLab Institute, in Stockholm, Sweden.